Clinical Trials Directory

Trials / Completed

CompletedNCT03110679

Randomized Double-blind Study on the Treatment of Osteoarthritis of the Bilateral Knee: Autologous Bone Marrow Concentrate vs. Hyaluronic Acid

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

OA-bi-Blind is a randomized double-blind study on the treatment of osteoarthritis of the Bilateral knee: autologous bone marrow concentrate vs. hyaluronic acid.

Detailed description

a randomized, controlled, double-blind study and we will be evaluated and compared the clinical and radiological results of concentrated autologous bone marrow against the hyaluronic acid in patients with bilateral knee osteoarthrosis . In randomization, one knee will be treated with autologous bone marrow concentrate and other knee with hyaluronic acid, then every patient is considered both in control and treatment group, limiting the heterogenity between groups and will not be informed of the knee assigned to the treatment group.

Conditions

Interventions

TypeNameDescription
BIOLOGICALinjection of autologous bone marrow concentrate
BIOLOGICALinjection of hyaluronic acid.

Timeline

Start date
2016-05-23
Primary completion
2016-11-01
Completion
2021-05-01
First posted
2017-04-12
Last updated
2021-08-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03110679. Inclusion in this directory is not an endorsement.